Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 15,310 | 15,524 | 11,790 | 12,986 | 13,956 |
| Cost of Goods | 9,117 | 9,026 | 7,036 | 7,719 | 7,650 |
| Gross Profit | 6,193 | 6,498 | 4,754 | 5,267 | 6,306 |
| Operating Expenses | 8,253 | 5,508 | 5,307 | 7,521 | 7,312 |
| Operating Income | -1,943 | 1,016 | -517 | -1,535 | -356 |
| Interest Expense | 29 | 45 | 25 | 47 | 30 |
| Other Income | 758 | -199 | 1,568 | 127 | 10 |
| Pre-tax Income | -1,214 | 772 | 1,026 | -1,455 | -376 |
| Income Tax | 300 | N/A | -141 | -45 | N/A |
| Net Income Continuous | -1,514 | 772 | 1,167 | -1,410 | -376 |
| Net Income | $-1,514 | $772 | $1,167 | $-1,410 | $-376 |
| EPS Basic Total Ops | -0.14 | 0.07 | 0.10 | -0.13 | 0.01 |
| EPS Basic Continuous Ops | -0.14 | 0.07 | 0.11 | -0.13 | -0.03 |
| EPS Diluted Total Ops | -0.14 | 0.06 | 0.14 | -0.13 | -0.03 |
| EPS Diluted Continuous Ops | -0.14 | 0.06 | 0.11 | -0.13 | -0.03 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.06 | 0.11 | -0.08 | -0.03 |
| EBITDA(a) | $-1,322 | $1,606 | $68 | $-942 | $235 |